InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by AKKARAJU SRINIVAS, Director. Officer active across 2 companies, notably Intercept Pharmaceuticals, INC.. Cumulatively, 8 filings have been logged. Total volume traded: €41.4m. The latest transaction was filed on 27 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations8 total
€7m570,000 shares@ €13.043917.9% of flow
Common Stock
SEC:0001209191-22-033141:0·
Ideal exit: 21 Feb 2023 (T+270)
07,737 shares0
Common Stock
SEC:0001104659-22-065916:0·
€15m1,215,000 shares@ €12.23687.4% of flow
Common Stock
SEC:0001209191-21-064987·
Ideal exit: 12 Aug 2022 (T+270)
€15m1,215,000 shares@ €12.23635.9% of flow
Common Stock
SEC:0001209191-21-064987:0·
Ideal exit: 12 Aug 2022 (T+270)
€2m208,500 shares@ €10.236412.6% of flow
Common Stock
SEC:0001209191-21-052814·
Ideal exit: 15 May 2022 (T+270)
€2m208,500 shares@ €10.23645.2% of flow
Common Stock
SEC:0001209191-21-052814:0·
Ideal exit: 15 May 2022 (T+270)
07,029 shares0
Common Stock
SEC:0001104659-21-075214·
07,029 shares0
Common Stock
SEC:0001104659-21-075214:0·
8 of 8 declarations
About AKKARAJU SRINIVAS
Akkaraju Srinivas is a Board Member at Intercept Pharmaceuticals, Inc. and Chinook Therapeutics, Inc. He brings his expertise in corporate governance and strategy to these companies. His role involves overseeing operations and ensuring that decisions made by the board are in the best interest of shareholders and stakeholders. With his experience, he contributes to strategic direction and risk management within these biopharmaceutical companies.
